Iovance Shares Jump on Rising Demand for Melanoma Cell Therapy
Iovance Biotherapeutics shares surged after Barron's reported strong demand for its melanoma drug is driving company growth, signaling durable commercial momentum.
Topic
Topic
Iovance Biotherapeutics shares surged after Barron's reported strong demand for its melanoma drug is driving company growth, signaling durable commercial momentum.
Iovance Biotherapeutics shares surged as strong demand for its melanoma drug drove company growth, signaling the therapy's uptake…